Skip to main content
Egyptian Journal of Radiology and Nuclear Medicine

Table 2 CT indices of the studied groups

From: Assessment of hepatic steatosis of potential living donor before liver transplantation using liver/spleen CT attenuation ratio compared to liver biopsy

 

Group A (n = 38)

Group B (n = 15)

P value

CTL

57.04 ± 4.48

50.02 ± 6.77

0.000*

CTS

45.4 ± 4.22

44.88 ± 4.7

0.697

CTL-S

11.64 ± 5.51

5.14 ± 6.04

0.000*

CTL/S

1.27 ± .15

1.11 ± .15

0.001*

RT/S

1.24 ± .15

1.09 ± .13

0.001*

LT/S

1.29 ± .16

1.15 ± .15

0.004*

M. right lobe attenuation

55.78 ± 4.78

48.67 ± 6.92

0.000*

M. left lobe attenuation

58.39 ± 4.62

51.41 ± 6.89

0.000*

  1. Data are presented as mean ± SD. CTL Liver attenuation, CTL_S Difference between liver and spleen attenuation, CTL/S Ratio of hepatic attenuation to splenic attenuation, CTS Splenic attenuation, RT/S Ratio of right hepatic attenuation to splenic attenuation, LT/S Ratio of left hepatic attenuation to splenic attenuation
Back to article page